195 related articles for article (PubMed ID: 8648699)
1. Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev.
Tan W; Schalling M; Zhao C; Luukkonen M; Nilsson M; Fenyö EM; Pavlakis GN; Schwartz S
J Virol; 1996 Jun; 70(6):3645-58. PubMed ID: 8648699
[TBL] [Abstract][Full Text] [Related]
2. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.
Martarano L; Stephens R; Rice N; Derse D
J Virol; 1994 May; 68(5):3102-11. PubMed ID: 8151775
[TBL] [Abstract][Full Text] [Related]
3. Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs.
Mikaélian I; Krieg M; Gait MJ; Karn J
J Mol Biol; 1996 Mar; 257(2):246-64. PubMed ID: 8609621
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.
Li J; Zhang X; Bai B; Zhang M; Ma W; Lin Y; Wang X; Wang XF
J Virol; 2022 Dec; 96(24):e0121022. PubMed ID: 36448796
[TBL] [Abstract][Full Text] [Related]
5. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
Chung H ; Derse D
J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal splice sites of equine infectious anaemia virus control Rev responsiveness.
Rosin-Arbesfeld R; Yaniv A; Gazit A
J Gen Virol; 2000 May; 81(Pt 5):1265-72. PubMed ID: 10769069
[TBL] [Abstract][Full Text] [Related]
7. Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays.
Jin J; Sturgeon T; Chen C; Watkins SC; Weisz OA; Montelaro RC
J Virol; 2007 Oct; 81(20):11226-35. PubMed ID: 17686839
[TBL] [Abstract][Full Text] [Related]
8. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
Liao HJ; Baker CC; Princler GL; Derse D
Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
[TBL] [Abstract][Full Text] [Related]
9. Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2.
Schiltz RL; Shih DS; Rasty S; Montelaro RC; Rushlow KE
J Virol; 1992 Jun; 66(6):3455-65. PubMed ID: 1316461
[TBL] [Abstract][Full Text] [Related]
10. Multiple RNA splicing and the presence of cryptic RNA splice donor and acceptor sites may contribute to low expression levels and poor immunogenicity of potential DNA vaccines containing the env gene of equine infectious anemia virus (EIAV).
Zhou W; Cook RF; Cook SJ; Hammond SA; Rushlow K; Ghabrial NN; Berger SL; Montelaro RC; Issel CJ
Vet Microbiol; 2002 Aug; 88(2):127-51. PubMed ID: 12135633
[TBL] [Abstract][Full Text] [Related]
11. Biological characterization of Rev variation in equine infectious anemia virus.
Belshan M; Harris ME; Shoemaker AE; Hope TJ; Carpenter S
J Virol; 1998 May; 72(5):4421-6. PubMed ID: 9557734
[TBL] [Abstract][Full Text] [Related]
12. A new RNA element located in the coding region of a murine endogenous retrovirus can functionally replace the Rev/Rev-responsive element system in human immunodeficiency virus type 1 Gag expression.
Wodrich H; Bohne J; Gumz E; Welker R; Kräusslich HG
J Virol; 2001 Nov; 75(22):10670-82. PubMed ID: 11602709
[TBL] [Abstract][Full Text] [Related]
13. The 5' RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production.
Butsch M; Hull S; Wang Y; Roberts TM; Boris-Lawrie K
J Virol; 1999 Jun; 73(6):4847-55. PubMed ID: 10233946
[TBL] [Abstract][Full Text] [Related]
14. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.
Schwartz S; Campbell M; Nasioulas G; Harrison J; Felber BK; Pavlakis GN
J Virol; 1992 Dec; 66(12):7176-82. PubMed ID: 1433510
[TBL] [Abstract][Full Text] [Related]
15. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA.
Nasioulas G; Zolotukhin AS; Tabernero C; Solomin L; Cunningham CP; Pavlakis GN; Felber BK
J Virol; 1994 May; 68(5):2986-93. PubMed ID: 8151769
[TBL] [Abstract][Full Text] [Related]
16. Molecular and biological characterization of equine infectious anemia virus Rev.
Carpenter S; Dobbs D
Curr HIV Res; 2010 Jan; 8(1):87-93. PubMed ID: 20210784
[TBL] [Abstract][Full Text] [Related]
17. A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element.
Zhang X; Li J; Zhang M; Bai B; Ma W; Lin Y; Guo X; Wang XF; Wang X
J Virol; 2022 Sep; 96(18):e0098622. PubMed ID: 36069548
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Rev expression by the equine infectious anaemia virus tat-rev mRNA Kozak sequence and its potential influence on viral replication.
Ma J; Zhang Z; Yao Q; Su C; Yin X; Wang X
J Gen Virol; 2016 Sep; 97(9):2421-2426. PubMed ID: 27411804
[TBL] [Abstract][Full Text] [Related]
19. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.
Rosin-Arbesfeld R; Rivlin M; Noiman S; Mashiah P; Yaniv A; Miki T; Tronick SR; Gazit A
J Virol; 1993 Sep; 67(9):5640-6. PubMed ID: 8394464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
